Sonoma Pharmaceuticals (SNOA) Change in Acquisitions & Divestments (2015)
Sonoma Pharmaceuticals' (SNOA) quarterly Change in Acquisitions & Divestments came in at $4.5 million in Q2 2015.
Sonoma Pharmaceuticals (SNOA) Change in Acquisitions & Divestments (2015) Analysis & Trends
Sonoma Pharmaceuticals' Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $4.5 million for Q2 2015.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $4.5 million in Q2 2015; TTM through Mar 2016 was $4.5 million, a N/A change from a year earlier, with the FY2016 full-year figure at $4.5 million, up 371.24% from the prior year.
- Change in Acquisitions & Divestments steadied at $4.5 million in Q2 2015 per SNOA's latest filing.
- Across five years, Change in Acquisitions & Divestments topped out at $4.5 million in Q2 2015 and bottomed at $4.5 million in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Sonoma Pharmaceuticals | 1.97 Mn | -428,888.50 | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 4.54 Mn |
| Jun 30, 2015 | 4.54 Mn |